Status:
COMPLETED
To Study Safety, Tolerability and Pharmacokinetics of AZD1305 in Healthy Male Japanese Subjects
Lead Sponsor:
AstraZeneca
Conditions:
Healthy
Eligibility:
MALE
20-40 years
Phase:
PHASE1
Brief Summary
The purpose is to study the safety of AZD1305, how AZD1305 is tolerated and how the medication is metabolised by the body ( how it is taken up into the body, distributed around the body and disappears...
Eligibility Criteria
Inclusion
- A body mass index (BMI=weight/height2) of 19 to 27 kg/m2
- Japanese males
Exclusion
- ECG findings outside normal reference ranges.
- Potassium outside normal reference ranges.
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2008
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00738322
Start Date
July 1 2008
End Date
October 1 2008
Last Update
June 30 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Fukuoka, Japan